Corvus Pharmaceuticals, Inc.
CRVS
$15.97
$0.161.01%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 236.71M | 56.75M | 65.69M | 74.41M | 44.21M |
| Total Receivables | 1.20M | 374.00K | 346.00K | 259.00K | 227.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 103.00K | 173.00K | 223.00K | 333.00K | 507.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.93M | 917.00K | 686.00K | 781.00K | 545.00K |
| Total Current Assets | 239.95M | 58.21M | 66.94M | 75.78M | 45.49M |
|
|
|||||
| Total Current Assets | 239.95M | 58.21M | 66.94M | 75.78M | 45.49M |
| Net Property, Plant & Equipment | 1.03M | 1.06M | 1.15M | 1.26M | 1.26M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.72M | 855.00K | 852.00K | 626.00K | 629.00K |
| Total Assets | 253.20M | 71.12M | 80.47M | 89.46M | 59.44M |
|
|
|||||
| Total Accounts Payable | 4.70M | 2.49M | 1.97M | 3.14M | 1.31M |
| Total Accrued Expenses | 6.78M | 6.25M | 5.16M | 4.67M | 3.58M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 428.00K | 403.00K | 379.00K | 355.00K | 319.00K |
| Total Finance Division Other Current Liabilities | 206.00K | 238.00K | 566.00K | 346.00K | 4.08M |
| Total Other Current Liabilities | 206.00K | 238.00K | 566.00K | 346.00K | 4.08M |
| Total Current Liabilities | 12.11M | 9.38M | 8.07M | 8.51M | 9.28M |
|
|
|||||
| Total Current Liabilities | 12.11M | 9.38M | 8.07M | 8.51M | 9.28M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 406.00K | 534.00K | 632.00K | 728.00K | 834.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 12.52M | 9.91M | 8.71M | 9.23M | 10.11M |
|
|
|||||
| Common Stock & APIC | 667.79M | 474.39M | 472.80M | 471.19M | 432.40M |
| Retained Earnings | -425.99M | -412.29M | -399.97M | -389.82M | -381.82M |
| Treasury Stock & Other | -1.13M | -896.00K | -1.06M | -1.15M | -1.25M |
| Total Common Equity | 240.68M | 61.21M | 71.77M | 80.23M | 49.33M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 240.68M | 61.21M | 71.77M | 80.23M | 49.33M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 240.68M | 61.21M | 71.77M | 80.23M | 49.33M |
|
|
|||||